Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan
· Delayed Price · Currency is TWD 387.50
-1.00 (-0.26%)
Apr 29, 2026, 1:24 PM CST
Sunmax Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 711.59 | 775.47 | 854.69 | 589.3 | 602.55 | Upgrade
|
| Short-Term Investments | 250 | 90 | 107.1 | 227.37 | 76.79 | Upgrade
|
| Cash & Short-Term Investments | 961.59 | 865.47 | 961.79 | 816.67 | 679.34 | Upgrade
|
| Cash Growth | 11.11% | -10.02% | 17.77% | 20.21% | -25.31% | Upgrade
|
| Accounts Receivable | 2.21 | 2.54 | 2.55 | 1.94 | 3.72 | Upgrade
|
| Other Receivables | 0.72 | 26.07 | 6.84 | 1.37 | 4.71 | Upgrade
|
| Receivables | 2.93 | 28.61 | 9.39 | 3.3 | 8.43 | Upgrade
|
| Inventory | 152.66 | 157.36 | 93.67 | 73.79 | 54.74 | Upgrade
|
| Other Current Assets | 25.9 | 41.08 | 14.08 | 11.81 | 45.06 | Upgrade
|
| Total Current Assets | 1,143 | 1,093 | 1,079 | 905.58 | 787.57 | Upgrade
|
| Property, Plant & Equipment | 911.64 | 939.2 | 904.32 | 604.39 | 485.56 | Upgrade
|
| Long-Term Investments | - | - | - | 10.3 | 17.18 | Upgrade
|
| Other Intangible Assets | 9.75 | 6.4 | 5.06 | 3.84 | 3.84 | Upgrade
|
| Long-Term Deferred Tax Assets | 28.89 | 37.71 | 53.39 | 20.76 | 17.32 | Upgrade
|
| Other Long-Term Assets | 30 | 19.15 | 117.33 | 248.41 | 172.55 | Upgrade
|
| Total Assets | 2,123 | 2,095 | 2,159 | 1,793 | 1,484 | Upgrade
|
| Accounts Payable | 7.25 | 18.27 | 11.98 | 21.77 | 14.95 | Upgrade
|
| Current Portion of Leases | 25.47 | 23.28 | 24.24 | 13.27 | 32.28 | Upgrade
|
| Current Income Taxes Payable | 72.08 | 67.76 | 89.03 | 82.94 | 70.84 | Upgrade
|
| Current Unearned Revenue | 22.05 | 73.85 | 202.57 | 60.09 | 122.95 | Upgrade
|
| Other Current Liabilities | 166.91 | 145.75 | 129.62 | 147.93 | 92.93 | Upgrade
|
| Total Current Liabilities | 293.76 | 328.91 | 457.43 | 326 | 333.95 | Upgrade
|
| Long-Term Leases | 93.87 | 121.94 | 144.78 | 49.82 | 66.9 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 91.02 | 103.06 | 105.19 | 57.16 | 22.16 | Upgrade
|
| Other Long-Term Liabilities | 26.95 | 28.23 | 25.59 | 35.02 | 37.43 | Upgrade
|
| Total Liabilities | 505.6 | 582.13 | 732.99 | 468 | 460.44 | Upgrade
|
| Common Stock | 544.63 | 544.63 | 544.63 | 544.63 | 544.63 | Upgrade
|
| Additional Paid-In Capital | 3.65 | 3.65 | 3.65 | 3.65 | 25.44 | Upgrade
|
| Retained Earnings | 1,067 | 973.11 | 892.8 | 778.61 | 460.46 | Upgrade
|
| Comprehensive Income & Other | 2.39 | -8.56 | -15.04 | -1.62 | -6.95 | Upgrade
|
| Shareholders' Equity | 1,618 | 1,513 | 1,426 | 1,325 | 1,024 | Upgrade
|
| Total Liabilities & Equity | 2,123 | 2,095 | 2,159 | 1,793 | 1,484 | Upgrade
|
| Total Debt | 119.33 | 145.21 | 169.02 | 63.09 | 99.18 | Upgrade
|
| Net Cash (Debt) | 842.26 | 720.26 | 792.78 | 753.58 | 580.16 | Upgrade
|
| Net Cash Growth | 16.94% | -9.15% | 5.20% | 29.89% | -25.59% | Upgrade
|
| Net Cash Per Share | 15.44 | 13.21 | 14.54 | 13.82 | 10.64 | Upgrade
|
| Filing Date Shares Outstanding | 54.46 | 54.46 | 54.46 | 54.46 | 54.46 | Upgrade
|
| Total Common Shares Outstanding | 54.46 | 54.46 | 54.46 | 54.46 | 54.46 | Upgrade
|
| Working Capital | 849.33 | 763.6 | 621.51 | 579.57 | 453.62 | Upgrade
|
| Book Value Per Share | 29.70 | 27.78 | 26.18 | 24.33 | 18.79 | Upgrade
|
| Tangible Book Value | 1,608 | 1,506 | 1,421 | 1,321 | 1,020 | Upgrade
|
| Tangible Book Value Per Share | 29.52 | 27.66 | 26.09 | 24.26 | 18.72 | Upgrade
|
| Land | 64.9 | 64.9 | - | - | - | Upgrade
|
| Buildings | 522.47 | 517.01 | 487.13 | 482.71 | - | Upgrade
|
| Machinery | 343.9 | 343.25 | 293.4 | 82.42 | 62.95 | Upgrade
|
| Construction In Progress | 3.99 | 0.3 | 17.79 | - | 331.26 | Upgrade
|
| Leasehold Improvements | 23.46 | 45.44 | 44.01 | 44.79 | 44.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.